Michael Taylor - Related publications

Affiliations: 
University of Kansas Medical Center, Kansas City, KS, United States 
Area:
Motor cortex: plasticity and stroke
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Bao Y, Mo JF. [Concordant point mutation of ETS-related gene () in tumor tissues from a synchronous multiple primary lung cancer: A case report]. Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences. 52: 971-974. PMID 33047739   
2020 Saurabh R, Nandi S, Sinha N, Shukla M, Sarkar RR. Prediction of survival rate and effect of drugs on cancer patients with somatic mutations of genes: An AI-based approach. Chemical Biology & Drug Design. 96: 1005-1019. PMID 33058465 DOI: 10.1111/cbdd.13668   
2020 Si W, Zhou B, Xie W, Li H, Li K, Li S, Deng W, Shi P, Yuan C, Ke T, Ren X, Tu X, Zeng X, Weigelt B, Rubin BP, et al. Angiogenic factor AGGF1 acts as a tumor suppressor by modulating p53 post-transcriptional modifications and stability via MDM2. Cancer Letters. PMID 33069768 DOI: 10.1016/j.canlet.2020.10.014   
2020 Kim MY, Shin JY, Kim JO, Son KH, Kim YS, Jung CK, Kang JH. Anti-tumor efficacy of CKD-516 in combination with radiation in xenograft mouse model of lung squamous cell carcinoma. Bmc Cancer. 20: 1057. PMID 33143663 DOI: 10.1186/s12885-020-07566-x   
2020 Yao JH, Zhang WQ, Shao Y, Zhu Y, Liu J, Jin GS, Yang Y. Molecular phenotype discordance between primary and synchronous metastatic lesions of breast cancer and its determinant role in guiding treatment decisions: a case report. American Journal of Translational Research. 12: 5866-5873. PMID 33042465   
2020 Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, Li X, Cao K, Deng H, He Y, Liao Q, Xiang B, Zhou M, Guo C, Zeng Z, et al. The role of microenvironment in tumor angiogenesis. Journal of Experimental & Clinical Cancer Research : Cr. 39: 204. PMID 32993787 DOI: 10.1186/s13046-020-01709-5   
2020 Pancaldi A, Peng L, Rhee DS, Dunn E, Forcucci JA, Belchis D, Pratilas CA. -associated metastatic abdominopelvic primitive neuroectodermal tumor with an rearrangement in a 16-yr-old female. Cold Spring Harbor Molecular Case Studies. 6. PMID 33028642 DOI: 10.1101/mcs.a005603   
2020 Weddell J, Chiney MS, Bhatnagar S, Gibbs JP, Shebley M. Mechanistic Modeling of Intra-Tumor Spatial Distribution of Antibody-Drug Conjugates: Insights into Dosing Strategies in Oncology. Clinical and Translational Science. PMID 33073529 DOI: 10.1111/cts.12892   
2020 Lopes MBS. World Health Ozganization 2017 Classification of Pituitary Tumors. Endocrinology and Metabolism Clinics of North America. 49: 375-386. PMID 32741477 DOI: 10.1016/j.ecl.2020.05.001   
2020 Ognjenovic NB, Bagheri M, Mohamed GA, Xu K, Chen Y, Mohamed Saleem MA, Brown MS, Nagaraj SH, Muller KE, Gerber SA, Christensen BC, Pattabiraman DR. Limiting Self-Renewal of the Basal Compartment by PKA Activation Induces Differentiation and Alters the Evolution of Mammary Tumors. Developmental Cell. PMID 33120014 DOI: 10.1016/j.devcel.2020.10.004   
2020 García-Heredia JM, Otero-Albiol D, Pérez M, Pérez-Castejón E, Muñoz-Galván S, Carnero A. Breast tumor cells promotes the horizontal propagation of EMT, stemness, and metastasis by transferring the MAP17 protein between subsets of neoplastic cells. Oncogenesis. 9: 96. PMID 33106480 DOI: 10.1038/s41389-020-00280-0   
2020 Meng L, Ding P, Liu S, Li Z, Sang M, Shan B. The emerging prospects of circular RNA in tumor immunity. Annals of Translational Medicine. 8: 1091. PMID 33145310 DOI: 10.21037/atm-19-4751   
2020 Mosa MH, Michels BE, Menche C, Nicolas AM, Darvishi T, Greten FR, Farin HF. A Wnt-induced phenotypic switch in cancer-associated fibroblasts inhibits EMT in colorectal cancer. Cancer Research. PMID 33055221 DOI: 10.1158/0008-5472.CAN-20-0263   
2020 Huang LT, Tsai CL, Huang SH, Chang MM, Chang WT, Cheng LH, Cheng HC. Depleting RhoA/Stress Fiber-Organized Fibronectin Matrices on Tumor Cells Non-Autonomously Aggravates Fibroblast-Driven Tumor Cell Growth. International Journal of Molecular Sciences. 21. PMID 33158289 DOI: 10.3390/ijms21218272   
2020 Ioakeim-Ioannidou M, MacDonald SM. Evolution of Care of Orbital Tumors with Radiation Therapy. Journal of Neurological Surgery. Part B, Skull Base. 81: 480-496. PMID 33072488 DOI: 10.1055/s-0040-1713894   
2020 Jog AP, Ronderos DM, Ali A, Niazi M, Diaz-Fuentes G. Malignant Epithelioid Neoplasm of the Brain. Cureus. 12: e10079. PMID 33005505 DOI: 10.7759/cureus.10079   
2020 Nakajima K, Raz A. T cell infiltration profile in musculoskeletal tumors. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. PMID 33095470 DOI: 10.1002/jor.24890   
2020 Xiong Y, Zhang Y, Xiong S, Williams-Villalobo AE. A Glance of p53 Functions in Brain Development, Neural Stem Cells, and Brain Cancer. Biology. 9. PMID 32932978 DOI: 10.3390/biology9090285   
2020 Song IH, Lee YS, Sun DI, Hong YK, Lee KY. Metachronous double primary neuroendocrine tumors in larynx and lung: a case report. The Journal of International Medical Research. 48: 300060520962928. PMID 33167723 DOI: 10.1177/0300060520962928   
2020 Marquard S, Thomann S, Weiler SME, Bissinger M, Lutz T, Sticht C, Tóth M, de la Torre C, Gretz N, Straub BK, Marquardt J, Schirmacher P, Breuhahn K. Yes-associated protein (YAP) induces a secretome phenotype and transcriptionally regulates plasminogen activator Inhibitor-1 (PAI-1) expression in hepatocarcinogenesis. Cell Communication and Signaling : Ccs. 18: 166. PMID 33097058 DOI: 10.1186/s12964-020-00634-6   
2020 Tariq MU, Idress R, Qureshi MB, Kayani N. Encapsulated papillary carcinoma of breast; a clinicopathological study of 25 cases and literature review with emphasis on high grade variant. Annals of Diagnostic Pathology. 49: 151613. PMID 32911448 DOI: 10.1016/j.anndiagpath.2020.151613   
2020 Vickman RE, Faget DV, Beachy P, Beebe D, Bhowmick NA, Cukierman E, Deng WM, Granneman JG, Hildesheim J, Kalluri R, Lau KS, Lengyel E, Lundeberg J, Moscat J, Nelson PS, et al. Deconstructing tumor heterogeneity: the stromal perspective. Oncotarget. 11: 3621-3632. PMID 33088423 DOI: 10.18632/oncotarget.27736   
2020 Merrill S, Sharma A, Carlin R, McCullough A, Porter A, Bendok B, Kouloumberis P. A Rare Intracranial Collision Tumor of Meningioma and Metastatic Uterine Adenocarcinoma: Case Report and Literature Review. World Neurosurgery. PMID 32987172 DOI: 10.1016/j.wneu.2020.09.108   
2020 Walens A, Lin J, Damrauer JS, McKinney B, Lupo R, Newcomb R, Fox DB, Mabe NW, Gresham J, Sheng Z, Sibley AB, De Buysscher T, Kelkar H, Mieczkowski PA, Owzar K, et al. Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence. Nature Communications. 11: 5017. PMID 33024122 DOI: 10.1038/s41467-020-18730-z   
2020 LeGout JD, Bailey RE, Bolan CW, Bowman AW, Chen F, Cernigliaro JG, Alexander LF. Multimodality Imaging of Abdominopelvic Tumors with Venous Invasion. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 200047. PMID 33064623 DOI: 10.1148/rg.2020200047   
2020 Yuan B, Li F, Li Y, Chen Y. Construction of a 13-Gene Signature as a Novel Prognostic Marker for Patients with Clear Cell Renal Cell Carcinoma and the Role of XCR1 in Cell Proliferation. Cancer Management and Research. 12: 4017-4027. PMID 33116819 DOI: 10.2147/CMAR.S250126   
2020 Lee K, Koo H, Kim Y, Kim D, Son E, Yang H, Lim Y, Hur M, Lee HW, Choi SW, Nam DH. Therapeutic Efficacy of GC1118, a Novel Anti-EGFR Antibody, against Glioblastoma with High EGFR Amplification in Patient-Derived Xenografts. Cancers. 12. PMID 33142709 DOI: 10.3390/cancers12113210   
2020 Shenoy A, Belugali Nataraj N, Perry G, Loayza Puch F, Nagel R, Marin I, Balint N, Bossel N, Pavlovsky A, Barshack I, Kaufman B, Agami R, Yarden Y, Dadiani M, Geiger T. Proteomic patterns associated with response to breast cancer neoadjuvant treatment. Molecular Systems Biology. 16: e9443. PMID 32960509 DOI: 10.15252/msb.20209443   
2020 Han PP, Zhang GQ, Li L, Yue L. Downregulation of USP33 inhibits Slit/Robo signaling pathway and is associated with poor patient survival of glioma. Journal of Neurosurgical Sciences. PMID 32972109 DOI: 10.23736/S0390-5616.20.04929-2   
2020 Pires A, Greenshields-Watson A, Jones E, Smart K, Lauder SN, Somerville M, Milutinovic S, Kendrick H, Hindley JP, French R, Smalley MJ, Watkins WJ, Andrews R, Godkin A, Gallimore A. Immune Remodelling of the Extracellular Matrix Drives Loss of Cancer Stem Cells and Tumor Rejection. Cancer Immunology Research. PMID 33023965 DOI: 10.1158/2326-6066.CIR-20-0070   
2020 Reese B, Silwal A, Daugherity E, Daugherity M, Arabi M, Daly P, Paterson Y, Woolford L, Christie A, Elias R, Brugarolas J, Wang T, Karbowniczek M, Markiewski MM. Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma. Journal of Immunology (Baltimore, Md. : 1950). PMID 33158953 DOI: 10.4049/jimmunol.2000511   
2020 Zhang P, Xia Q, Liu L, Li S, Dong L. Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy. Frontiers in Molecular Biosciences. 7: 562798. PMID 33102518 DOI: 10.3389/fmolb.2020.562798   
2020 Ashrafizadeh M, Zarabi A, Hushmandi K, Moghadam ER, Hashemi F, Daneshi S, Hashemi F, Tavakol S, Mohammadinejad R, Najafi M, Dudha N, Garg M. C-Myc signaling pathway in treatment and prevention of brain tumors. Current Cancer Drug Targets. PMID 33069197 DOI: 10.2174/1568009620666201016121005   
2020 Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nature Communications. 11: 5077. PMID 33033240 DOI: 10.1038/s41467-020-18916-5   
2020 Liu H, Yang C, Zhao X, Le J, Wu G, Wei J, Liang Y, Qian W. Genotyping on ctDNA Identifies Shifts in Mutation Spectrum Between Newly Diagnosed and Relapse/Refractory DLBCL. Oncotargets and Therapy. 13: 10797-10806. PMID 33122918 DOI: 10.2147/OTT.S275334   
2020 He D, Wang D, Lu P, Yang N, Xue Z, Zhu X, Zhang P, Fan G. Single-cell RNA sequencing reveals heterogeneous tumor and immune cell populations in early-stage lung adenocarcinomas harboring EGFR mutations. Oncogene. PMID 33144684 DOI: 10.1038/s41388-020-01528-0   
2020 Metz EP, Wuebben EL, Wilder PJ, Cox JL, Datta K, Coulter D, Rizzino A. Tumor quiescence: elevating SOX2 in diverse tumor cell types downregulates a broad spectrum of the cell cycle machinery and inhibits tumor growth. Bmc Cancer. 20: 941. PMID 32998722 DOI: 10.1186/s12885-020-07370-7   
2020 Gardell JL, Matsumoto LR, Chinn H, DeGolier KR, Kreuser SA, Prieskorn B, Balcaitis S, Davis A, Ellenbogen RG, Crane CA. Human macrophages engineered to secrete a bispecific T cell engager support antigen-dependent T cell responses to glioblastoma. Journal For Immunotherapy of Cancer. 8. PMID 33122397 DOI: 10.1136/jitc-2020-001202   
2020 Sabbatino F, Scognamiglio G, Liguori L, Marra A, Anniciello AM, Polcaro G, Dal Col J, Caputo A, Peluso AL, Botti G, Zeppa P, Ferrone S, Pepe S. Peritumoral Immune Infiltrate as a Prognostic Biomarker in Thin Melanoma. Frontiers in Immunology. 11: 561390. PMID 33117345 DOI: 10.3389/fimmu.2020.561390   
2020 Pasqualini C, Kozaki T, Bruschi M, Nguyen THH, Minard-Colin V, Castel D, Grill J, Ginhoux F. Modeling the Interaction between the Microenvironment and Tumor Cells in Brain Tumors. Neuron. PMID 33065047 DOI: 10.1016/j.neuron.2020.09.018   
2020 Zhou YZ, Zhu RL, Ouyang JZ, Yu KL, Wang ZZ, Li QJ, Zhou JX. [The therapeutic outcomes of ultrasound-guided percutaneous radiofrequency therapy for subcardiac liver malignant tumor]. Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]. 58: 770-775. PMID 32993264 DOI: 10.3760/cma.j.cn112139-20191206-00595   
2020 Huang YL, Shiau C, Wu C, Segall JE, Wu M. The architecture of co-culture spheroids regulates tumor invasion within a 3D extracellular matrix. Biophysical Reviews and Letters. 15: 131-141. PMID 33033500 DOI: 10.1142/s1793048020500034   
2020 Liu WH, Mrozek-Gorska P, Wirth AK, Herold T, Schwarzkopf L, Pich D, Völse K, Melo-Narváez MC, Carlet M, Hammerschmidt W, Jeremias I. Inducible transgene expression in PDX models in vivo identifies KLF4 as a therapeutic target for B-ALL. Biomarker Research. 8: 46. PMID 32944247 DOI: 10.1186/s40364-020-00226-z   
2020 Gu X, Yu J, Chai P, Ge S, Fan X. Novel insights into extrachromosomal DNA: redefining the onco-drivers of tumor progression. Journal of Experimental & Clinical Cancer Research : Cr. 39: 215. PMID 33046109 DOI: 10.1186/s13046-020-01726-4   
2020 Ge R, Fang HF, Chang YQ, Li Z, Liu CF. [Clinicopathological features of polymorphous low-grade neuroepithelial tumor of the young]. Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology. 49: 1131-1135. PMID 33152817 DOI: 10.3760/cma.j.cn112151-20200213-00086   
2020 Kobayashi Y, Mishima K, Adachi JI, Suzuki T, Sasaki A, Nishikawa R. [Glioblastoma Mimicking Meningioma Recurrence: A Case Report]. Brain and Nerve = Shinkei Kenkyu No Shinpo. 72: 1105-1111. PMID 33051400 DOI: 10.11477/mf.1416201657   
2020 Lin B, Du L, Li H, Zhu X, Cui L, Li X. Tumor-infiltrating lymphocytes: Warriors fight against tumors powerfully. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 132: 110873. PMID 33068926 DOI: 10.1016/j.biopha.2020.110873   
2020 Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017. Neuro-Oncology. 22: iv1-iv96. PMID 33123732 DOI: 10.1093/neuonc/noaa200   
2020 Mueller O, Thomassen J, Wiedemann J, Sure U, Sixt SU. Enzymatic activity of extracellular circulating proteasome in the CSF of patients with malignant intrinsic and metastatic brain tumors: proof of concept. Journal of Neurosurgical Sciences. PMID 32989975 DOI: 10.23736/S0390-5616.20.05112-7   
2020 Zhou H, Qin F, Chen C. Designing Hypoxia-Responsive Nanotheranostic Agents for Tumor Imaging and Therapy. Advanced Healthcare Materials. e2001277. PMID 32985141 DOI: 10.1002/adhm.202001277